Plasma proteomics of differential outcome to long‐term therapy in children with idiopathic pulmonary arterial hypertension
- 1 June 2012
- journal article
- research article
- Published by Wiley in Proteomics – Clinical Applications
- Vol. 6 (5-6) , 257-267
Abstract
Purpose: The prognosis for children with IPAH unresponsive to therapy is poor. We investigated the plasma proteome for a molecular basis of good versus poor outcome to long‐term vasodilator therapy.Experimental design: Plasma was collected at baseline or shortly after therapy initiation and following chronic vasodilator therapy, then divided into those with good outcome (n = 8), and those with a poor outcome (n = 7). To identify proteins unique to either outcome, we used differential gel electrophoresis and mass spectrometry. Results were confirmed by commercial enzyme‐linked immunosorbent assay.Results: Before and after therapy, SAA‐4 was 4‐fold lower in those with good outcome compared to those with poor outcome, while serum paraoxonase/arylesterase‐1 was increased 2‐fold in those with good outcome versus poor outcome. After therapy, haptoglobin and hemopexin were 1.45‐ and 1.8‐fold lower, respectively, in those with a good versus poor outcome. Among those with a good outcome, SAP was 1.3‐fold lower prior to therapy.Conclusions and clinical relevance: SAP and SAA‐4 regulate circulating mononuclear phagocytes. As such, they may contribute to the differential response to chronic vasodilator therapy in the context of inflammation in IPAH.Keywords
Funding Information
- National Institutes of Health (NIH) Specialized Centers of Clinically Oriented Research (HL-084923-02)
- NIH (HL-014985-35)
- Jayden DeLuca Foundation (M01-RR00069)
This publication has 61 references indexed in Scilit:
- Endothelin-1, the Unfolded Protein Response, and Persistent InflammationAmerican Journal of Respiratory Cell and Molecular Biology, 2012
- Recent progress in understanding pediatric pulmonary hypertensionCurrent Opinion in Pediatrics, 2011
- Medical Therapy for Pediatric Pulmonary Arterial HypertensionThe Journal of Pediatrics, 2010
- Pulmonary arterial hypertension in children: Diagnostic work-up and challengesProgress in Pediatric Cardiology, 2009
- Serum Amyloid P Inhibits Fibrosis Through FcγR-Dependent Monocyte-Macrophage Regulation in VivoScience Translational Medicine, 2009
- The interaction between urokinase receptor and vitronectin in cell adhesion and signallingEuropean Journal of Cell Biology, 2008
- Analysis of a G protein-coupled receptor for neurotensin by liquid chromatography–electrospray ionization–mass spectrometryAnalytical Biochemistry, 2008
- Pulmonary vascular input impedance is a combined measure of pulmonary vascular resistance and stiffness and predicts clinical outcomes better than pulmonary vascular resistance alone in pediatric patients with pulmonary hypertensionAmerican Heart Journal, 2008
- Two-dimensional fluorescence difference gel electrophoresis for comparative proteomics profilingNature Protocols, 2006
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976